Technologies for the next generation of antibody therapies.
AAX Biotech's investors include Trio Impact Invest, Life Science Invest, Phase2Phase Biopharma, Northislet, Karolinska Institutet Holding.
AAX Biotech is headquartered in Stockholm, Sweden.
Technologies for the next generation of antibody therapies.
AAX Biotech is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AAX Biotech — Funding & Investors." VCBacked, February 19, 2026, https://www.vcbacked.co/company/aax-biotech. Accessed September 30, 2026.
VCBacked. (2026). AAX Biotech — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/aax-biotech
{{cite web |title=AAX Biotech — Funding & Investors |url=https://www.vcbacked.co/company/aax-biotech |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated